NCT00657839View on ClinicalTrials.gov

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

June 30, 2006

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

10 mg Vardenafil bid

DRUG

Placebo

Matching placebo

Trial Locations (15)

20251

Hamburg

20354

Hamburg

21255

Tostedt

24105

Kiel

35039

Marburg

40210

Düsseldorf

45468

Mülheim

49076

Osnabrück

51373

Leverkusen

81925

München

82319

Starnberg

83022

Rosenheim

88400

Biberach

92637

Weiden

04105

Leipzig

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY